Constitutional t(16;22)(p13.3;q11.2∼12) in a primitive neuroectodermal tumor of the pineal region

Cancer Genetics and Cytogenetics

Volumn 142, Issue 1, 2003, Pages 73-76

  Sawyer, Jeffrey R ^a   Sammartino, Gael ^b   Husain, Muhammad ^a   Linskey, Mark E ^b  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SUSCEPTIBILITY; CASE REPORT; CHROMOSOME 22Q; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; FEMALE; GENE LOCUS; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; INFANT; NEUROECTODERM TUMOR; PINEAL BODY TUMOR; PRIORITY JOURNAL; SMALL CELL SARCOMA;

EID: 0345268779     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00735-5     Document Type: Article

References (25)

1. Mulvihill J.J. Clinical genetics of pediatric cancer. Pizzo P.A., Poplack D.G. Principles and practice of pediatric oncology. 1989;19-38 Lippincott, Philadelphia.
2. Lindblom A., Sandelin K., Iselius L., Dumanski J., White I., Nordenskjold M., Larsson C. Predisposition for breast cancer in carriers of constitutional translocation 11q;22q. Am J Hum Genet. 54:1994;871-876.
3. Richard F., Muleris M., Couturier J., Gerbault-Seureau M., Lombard M., Dutrillaux B. Constitutional balanced translocations in patients with solid tumors. Cancer Genet Cytogenet. 61:1992;50-52.
4. Park J.P., Chaffee S., Noll W.W., Rhodes C.H. Constitutional de novo t(1;22)(p22;q11.2) in ependymoma. Cancer Genet Cytogenet. 86:1996;150-152.
5. Savasan S., Lorenzana A., Williams J.A., Mohamed A.N., Ravindranath Y., Zielenska M., Hamre M., Haas J.E., Rector F., Sawaf H., Abella E. Constitutional balanced translocation in alveolar rhabdomyosarcoma. Cancer Genet Cytogenet. 105:1998;50-54.
6. Heim S., Mitelman F. Cancer cytogenetics. 2nd edition:1995;Wiley-Liss, New York.
7. Sawyer J.R., Swanson C.M., Lukacs J.L., Nicholas R.W., North P.E., Thomas J.R. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors. Cancer. 82:1998;474-483.
8. ISCN. An international system for human cytogenetic nomenclature. F Mitelman, editor. Basel: S. Karger, 1995.
9. Sawyer J.R., Lukacs J.L., Munshi N., Desikan K.R., Singhal S., Mehta J., Siegel D., Shaughnessy J., Barlogie B. Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping. Blood. 92:1998;4269-4278.
10. Rorke L.B., Packer R.J., Biegel J.A. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. definition of an entity J Neurosurg. 85:1996;56-65.
11. Burger P.C., Yu I.-T., Tihan T., Friedman H.S., Strother D.R., Kepner J.L., Duffner P.K., Kun L.E., Perlman E.J. Atypical teratoid/rhabdoid tumor of the central nervous system. a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study Am J Surg Pathol. 22:1998;1083-1092.
12. Biegel J.A., Fogelgren B., Zhou J.-Y., James C.D., Janss A.J., Allen J.C., Zagzag D., Raffel C., Rorke L.B. Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system. Clin Cancer Res. 6:2000;2759-2763.
13. Sawyer J.R., Goosen L.S., Swanson C.M., Tomita T., de Leon G.A. A new reciprocal translocation (12;22)(q24.3;q11.2-12) in a malignant rhabdoid tumor of the brain. Cancer Genet Cytogenet. 101:1998;62-67.
14. Huisman T.A., Brandner S., Niggli F., Betts D.R., Boltshauser E., Martin E. Malignant rhabdoid tumor of the brain. quantitative 1H MR-spectroscopy and cytogenetics Neuropediatrics. 31:2000;159-161. [letter].
15. Hart M.N., Earle K.M. Primitive neuroectodermal tumors of the brain in children. Cancer. 32:1973;890-897.
16. Rorke L.B. The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol. 42:1983;1-15.
17. Lantos P.L., Vandenberg S.R., Kleihues P. Tumors of the nervous system. Graham D.I., Lantos P.L. Greenfield's neuropathology. 6th edition:1997;583-795 Arnold, London.
18. Rainho C.A., Rogatto S.R., de Moraes L.C., Barbieri-Neto J. Cytogenetic study of pineocytoma. Cancer Genet Cytogenet. 64:1992;127-132.
19. Bello J.M., Rey J.A., De Campos J.M., Kusak M.E. Chromosomal abnormalities in pineocytoma. Cancer Genet Cytogenet. 71:1993;185-186.
20. Griffin C.A., Hawkins A.L., Packer R.J., Rorke L.B., Emanuel B.S. Chromosome abnormalities in pediatric brain tumors. Cancer Res. 48:1988;175-180.
21. Sreekantaiah C., Jockin H., Brecher M.L., Sandberg A.A. Interstitial deletion of chromosome 11q in a pineoblastoma. Cancer Genet Cytogenet. 39:1989;125-131.
22. Bigner S.H., McLendon R.E., Fuchs H., McKeever P.E., Friedman H.S. Chromosomal characteristics of childhood brain tumors. Cancer Genet Cytogenet. 97:1997;125-134.
23. Kees U.R., Biegel J.A., Ford J., Ranford R.P., Peroni S.E., Hallam L.A., Parmiter A.H., Willoughby M.L., Spagnolo D. Enhanced MYCN expression and isochromosome 17q in pineoblastoma cell lines. Genes Chromosomes Cancer. 9:1994;129-135.
24. Kees U., Spangnolo D., Hallam L.A., Ford J., Ranford R., Baker D.L., Callen D.F., Biegel J.A. A new pineoblastoma cell line, PER-480, with der(10)t(10;17), der (16)t(1;16), and enhanced MYC expression in the absence of gene amplification. Cancer Genet Cytogenet. 100:1998;159-164.
25. Rickert C.H., Simon R., Bergmann M., Dockhorn-Dworniczak B., Paulus W. Comparative genomic hybridization in pineal parenchymal tumors. Genes Chromosomes Cancer. 30:2001;99-104.